Cargando…
Serum Hepcidin Predicts Uremic Accelerated Atherosclerosis in Chronic Hemodialysis Patients with Diabetic Nephropathy
BACKGROUND: Hepcidin, as a regulator of body iron stores, has been recently discovered to play a critical role in the pathogenesis of anemia of chronic disease. Atherosclerotic cardiovascular disease is the most common complication and the leading cause of death in chronic hemodialysis (CHD) patient...
Autores principales: | Li, Han, Feng, Su-Juan, Su, Lu-Lu, Wang, Wei, Zhang, Xiao-Dong, Wang, Shi-Xiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830316/ https://www.ncbi.nlm.nih.gov/pubmed/25963357 http://dx.doi.org/10.4103/0366-6999.156781 |
Ejemplares similares
-
Correlation of Lower Concentrations of Hydrogen Sulfide with Activation of Protein Kinase CβII in Uremic Accelerated Atherosclerosis Patients
por: Wang, Wei, et al.
Publicado: (2015) -
Serum hepcidin may be a novel uremic toxin, which might be related to erythropoietin resistance
por: Lee, Sung Woo, et al.
Publicado: (2017) -
Relation between high serum hepcidin-25 level and subclinical atherosclerosis and cardiovascular mortality in hemodialysis patients
por: Yayar, Özlem, et al.
Publicado: (2018) -
Serum Hepcidin-25 and All-Cause Mortality in Patients Undergoing Maintenance Hemodialysis
por: Zou, Lu-Xi, et al.
Publicado: (2021) -
Hepcidin as a Biomarker of Impaired Renal Function in Rat Models for Chronic Allograft Nephropathy
por: Xue, Dong, et al.
Publicado: (2016)